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ABSTRACT
Objectives Using strong structuration theory, we aimed 
to understand the adoption and implementation of an 
electronic clinical audit and feedback tool to support 
medicine optimisation for patients in primary care.
Design This is a qualitative study informed by strong 
structuration theory. The analysis was thematic, using a 
template approach. An a priori set of thematic codes, based 
on strong structuration theory, was developed from the 
literature and applied to the transcripts. The coding template 
was then modified through successive readings of the data.
Setting Clinical commissioning group in the south of 
England.
Participants Four focus groups and five semi-structured 
interviews were conducted with 18 participants purposively 
sampled from a range of stakeholder groups (general 
practitioners, pharmacists, patients and commissioners).
Results Using the system could lead to improved 
medication safety, but use was determined by broad 
institutional contexts; by the perceptions, dispositions and 
skills of users; and by the structures embedded within 
the technology. These included perceptions of the system 
as new and requiring technical competence and skill; the 
adoption of the system for information gathering; and 
interactions and relationships that involved individual, 
shared or collective use. The dynamics between these 
external, internal and technological structures affected the 
adoption and implementation of the system.
Conclusions Successful implementation of information 
technology interventions for medicine optimisation 
will depend on a combination of the infrastructure 
within primary care, social structures embedded in the 
technology and the conventions, norms and dispositions 
of those utilising it. Future interventions, using electronic 
audit and feedback tools to improve medication safety, 
should consider the complexity of the social and 
organisational contexts and how internal and external 
structures can affect the use of the technology in order to 
support effective implementation.
INTRODUCTION
Prescribing medicines to patients is the most 
common clinical intervention in primary 
care. However, with high volumes of medi-
cines prescribed in primary care,1 the 
prevalence of repeat prescribing and the 
increased burden and complexity of multi-
morbidity and related polypharmacy,2 3 there 
is an increased likelihood that prescribing 
or monitoring errors can occur.4 5 Recent 
studies using prescribing safety indicators 
to investigate the prevalence of hazardous 
prescribing in primary care found 5.2%–
5.5% of patients to be at risk of potentially 
hazardous prescribing and 7.6%–11.8% of 
patients not receiving recommended moni-
toring tests.6 7 Some medication errors may 
not lead to harm; however, approximately 
13% of patients have experienced an adverse 
drug event after receiving prescription medi-
cation in primary care, and many of those 
have been serious enough for patients to seek 
medical assistance at hospital.8 9 The moni-
toring of patients in receipt of prescription 
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Strengths and limitations of this study
 ► This is the first study to explore the implementation 
of electronic audit and feedback systems to improve 
medication safety in primary care using strong 
structuration theory.
 ► Strong structuration theory was found to be 
particularly valuable for unpicking why the system 
was used and the different motivations, ambitions, 
aims and attitudes of a range of stakeholders.
 ► This was an exploratory study that relied mainly on 
interview and focus group data from a number of key 
stakeholders located in one clinical commissioning 
group in England.
 ► Additional insights may have been gained by 
undertaking ethnographic observation to discover 
exactly the ways people utilised the electronic 
medicines optimisation system (EMOS).
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medication is therefore considered important in order to 
avoid potentially serious adverse drug events.
In the UK, national and local policies have set out 
recommendations for medication safety improve-
ment.10–12 ‘An Organisation with a Memory’13 set out the 
necessity for the establishment of a patient safety culture 
within healthcare organisations. This emphasised the 
importance of organisational practices. Policy has also set 
out how the utilisation of information technology (IT) 
presents opportunities to fulfil medication safety require-
ments and that the contribution of information systems 
should be maximised.11 This was further enhanced by 
Department of Health recommendations in the report 
‘Building a Safer NHS for Patients: Improving Medica-
tion Safety’,10 which recommended that steps to safer 
prescribing may include the implementation of effective 
IT systems particularly those systems that might highlight 
and give warnings to medical staff of prescription errors. 
Similar recommendations have suggested there is a need 
to develop systems that optimise the use of medicines 
and that this might include improved electronic decision 
support for clinicians.12 Locally, the clinical commis-
sioning group (CCG) that formed the setting for this 
study operated a prescribing incentive scheme designed 
to improve the quality of prescribing, to respond to the 
requirements of national guidelines and to reduce exces-
sive prescribing and costs, which was incentivised by small 
financial rewards for general practices.14
Healthcare IT systems may be useful for monitoring 
medication usage. However, the implementation of such 
IT has not always been successful, with technology being 
resisted, not used effectively or used differently than was 
planned. Previous research has suggested that reasons for 
this might reside in the design and functionality of the 
technology. Poorly designed or implemented IT systems 
have been seen to create cognitive overload15 and disrupt 
workflow.16 Furthermore, IT systems may be utilised in 
ways unintended by developers, either to overcome prob-
lems with design or as new uses for the technology become 
apparent.17–19 However, such tailoring of systems suggests 
a dynamic where implementation actually involves inter-
pretation and adaptation of systems to fit existing work 
practices or changes to work practices in order to adapt 
to the new system.20–25 In other words, the success or 
failure of an IT implementation could be seen as being 
shaped by interactions between the technology, the users 
and the social and organisational processes.26–28 This 
sociotechnical view, rather than focusing only on the 
functionality of systems, takes into account the complex 
nature of healthcare and the cultural, social and organi-
sational aspects of the workplaces.22–29
Strong structuration theory (SST) has been proposed 
as a way of examining these sociotechnical aspects of 
healthcare IT implementation.30 It is based on Giddens’ 
structuration theory, which proposed a relationship 
between structures (such as social norms, political and 
economic institutions) and agency (people’s actions 
and choices).31 According to Stones,30 SST extends this 
structure–agency relationship to include the following 
elements (see figure 1):32
 ► External structures, which are the physical social or 
economic context in which action is contemplated. 
External structures are built through social 
positions, practices and networks of social 
Figure 1 Strong structuration theory incorporating a technology dimension (adapted from Stones30), from Greenhalgh and 
Stones 32
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relationships.29 32 These could include hierarchical 
relationships between employers and employees, 
professional roles, local and national guidelines, 
governance measures, regulations, professional 
codes of practice, as well as local work practices and 
interactions among groups of stakeholders.30 32
 ► Internal structures, which are manifested in two ways: 
first, as the skills, dispositions, ambitions, attitudes, 
values, past experiences of actors and ways of viewing 
the world; second, as the actors’ knowledge of rules, 
conventions, obligations and social norms, which may 
involve partial understandings and past experiences. 
These inform how one is supposed to act in specific 
situations in the here and now, based on the agents 
understanding of external structures.30 32 33
 ► Agency, which is how and why agents draw on internal 
structures to act in particular ways in specific 
situations.32
 ► Outcome, which is the way agency affects external or 
internal structures and how they are maintained or 
changed.32
Stones and Greenhalgh32 further explained the role 
of technology in SST: rather than there being symmetry 
between technology and human actors, they are instead 
separate and may act in different ways.32 Technology 
incorporates procedures, codes, material properties 
and standards that can enable or constrain use19 32–34; it 
is therefore seen as shaping human actions by making 
certain actions possible.35 Previous studies29 34 suggest that 
SST can illuminate the implementation and adoption of 
IT by understanding how people ‘take action with respect 
to technologies’; in other words, what people actually do 
with the systems and to what effect.32 SST has been previ-
ously used to understand the ways a large-scale healthcare 
IT intervention, designed to assist patients and general 
practitioners (GPs) to book hospital outpatient appoint-
ments, was resisted or adopted.34
This study uses SST to examine a new electronic 
medicines optimisation system (EMOS)36 that was imple-
mented in a primary care locality. The EMOS allows 
different stakeholders—GPs, CCG managers, pharma-
cists, general practice managers and patients—access to 
real-time anonymised patient data, including medical 
diagnoses, prescribed medications and laboratory test 
results. It comprises a secure patient database and a 
web-based user interface that extracts patient-specific 
data from the general practice clinical record system. 
The interface provides a number of user functions; these 
include reviewing a specific patient health record, iden-
tifying patients who are at risk of a medication-related 
adverse event, such as those who are on inappropriate 
combinations of drugs or those who have not received 
appropriate monitoring and carrying out clinical audits 
on a subset of patients.36 The EMOS also allowed clini-
cians and managers in the health locality to audit 
prescribing practices across general practices and make 
comparisons against national guidelines. Patients have 
access to the system through a patient passport, which 
allows them to view their medications and test results. In 
this context, it was felt that SST would unpick the ways in 
which users of the system drew on their dispositions, atti-
tudes, skills and ambitions and on their knowledge of and 
understanding of external structures to engage with the 
technology. Therefore, we aimed to examine the specific 
question: ‘In what ways did external, internal and tech-
nological structures impact on the implementation and 
adoption of the EMOS?’
METHODS
Study design and setting
Our study used a qualitative design. The study setting 
was a CCG in the south of England, which was chosen 
because it was an early adopter of the EMOS and had all 
general practices signed up to the system. The CCG was 
relatively small in size (17 separate general practices, and 
approximately 140 000 patients). Medicines management 
activities at the CCG were undertaken by three clinical 
pharmacists (including participants CCGP1 and CCGP2) 
and two pharmacy technicians. Additionally, one GP 
(participant GP1) operated as prescribing lead for the 
CCG. In the English National Health Service (NHS), a 
CCG is a clinically led statutory NHS body responsible for 
the planning and commissioning of healthcare services 
for their local area and cover groups of general prac-
tices within that area. The sampling frame was people 
within the CCG’s geographical area who represented the 
stakeholder groups. This included doctors, pharmacists, 
general practice managers and patients.
Understanding the background
Prior to data collection, we undertook actions to build a 
picture of the system and the context in which it was to 
be used. Authors MJ and RLH were given an overview of 
the system in a preliminary meeting with the study CCG 
prior to data collection. In addition, MJ visited a sepa-
rate CCG in the north of England that was utilising the 
EMOS. Web-based materials relating to the system were 
read prior to data collection.36
Recruitment and data collection
Individual participants were recruited on a purposive 
basis via the CCG or through community pharmacy 
networks to represent the different stakeholder groups 
(see table 1).
Potential participants were contacted by telephone or 
email. Five semi-structured interviews (lasting between 
20 and 50 min) were conducted with three GPs and two 
CCG pharmacists, who were known to be using the system 
and had specific roles that required the use of the EMOS 
between August and December 2014. Four homogeneous 
focus groups (lasting between 57 and 112 min) were also 
conducted between September and December 2014, each 
with a specific group of stakeholders: GPs (2), commu-
nity pharmacists (4), patients (4) and general practice 
managers (4). No repeat interviews were conducted, 
although one GP was interviewed and also participated 
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in a focus group. Each focus group was conducted with 
a different specific type of stakeholder, as this was felt to 
facilitate free and open discussion.
Topic guides for the interviews and focus groups were 
developed by reading relevant literature examining the 
implementation of IT in healthcare settings.16 17 20 23 24 Both 
interviews and focus groups were conducted to illicit indi-
vidual thoughts and opinions and to promote discussion 
among specific homogeneous groups of stakeholders. In 
the interviews and focus groups, we explored experiences 
of working with the EMOS, perceptions of the system, 
benefits and drawbacks, organisational structures and roles 
required for its use and the circumstances under which it 
was considered most effective. Data collection continued 
until saturation was reached, and no new themes emerged 
from the interviews and focus groups. The interviews and 
focus groups were carried out by a male research associate 
in medication safety trained and experienced in qualitative 
health research who holds an MSc in Health Psychology 
(MJ). The focus groups were co-facilitated by a female 
freelance research pharmacist experienced in qualita-
tive methodology and with a PhD in Medicines Safety in 
Primary Care (RLH). The researchers were not known to 
the participants prior to the study. Four interviews were 
conducted by telephone and one at the CCG offices. The 
focus groups were conducted at the CCG offices or at a local 
hotel solely with the participants, RLH and MJ present. All 
participants gave written informed consent to take part in 
the study and for the interviews and focus groups to be 
audio recorded and transcribed verbatim. Ethical approval 
for the study was granted by the Preston NHS Research 
Ethics Committee (reference 14/NW/0113).
Analysis
The analysis was thematic, using a template approach.37 
Template analysis involves the summarising of themes 
Table 1 Case study participants
Participants Role How they used the EMOS
Interviews
GP1-INT General practitioner In general practice and prescribing lead for the clinical commissioning group 
(CCG). Worked with the medicines management team in supporting the 
adoption of the EMOS by the CCG. Used the EMOS to send alerts to GPs.
GP2 General practitioner In general practice and respiratory lead for the CCG. Utilised the EMOS to 
undertake audits of prescribing relating to respiratory conditions.
GP3 General practitioner In general practice.
CCGP1 (additional 
observation as part 
of interview)
CCG pharmacist Utilised the EMOS to undertake medication reviews with care home patients.
CCGP2 CCG pharmacist CCG medicines management team. Used the EMOS to run audits centrally at 
the CCG and then alert clinicians locally.
Focus group A—general practitioners
GP4 General practitioner In general practice.
GP1-FG General practitioner In practice and as prescribing lead for the CCG.
Focus group B—community pharmacists
CP1 Community pharmacist Aware of, but no access.
CP2 Community pharmacist Aware of, but no access.
CP3 Community pharmacist Aware of, but no access.
CP4 Community pharmacist Aware of, but no access.
Focus group C—patients
Pt1 Patient Access through patient passport.
Pt2 Patient Access through patient passport.
Pt3 Patient Access through patient passport.
Pt4 Patient Access through patient passport.
Focus group D—general practice managers
GPM1 General practice manager In general practice.
GPM2 General practice manager In general practice.
GPM3 General practice manager In general practice.
GPM4 General practice manager In general practice.
CCG, clinical commissioning group; EMOS, electronic medicines optimisation system.
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through a coding template. Often, template analysis 
begins with an a priori set of themes. New themes are 
then added, or existing themes revised, as data are iter-
atively analysed in a process of developing a template.37 
An a priori set of thematic codes based on SST was devel-
oped from the literature.30 32 34 38 These included external 
structures such as national or local policies, guidelines 
and governance; interactions, including relationships, 
conflicts and communication; internal structures of 
agents, including dispositions, skills, attitudes and cogni-
tive demands; rules and contextuality, including routines, 
social norms and regulations; and technological struc-
tures, including the social structures built into the 
technology. This set of codes was applied to the transcripts 
by MJ and documented using the QSR NVivo 10 appli-
cation. The coding template was then modified through 
successive readings of the data and discussions with other 
authors. The template was then internally reviewed for 
completeness by MJ and DLP (who had independently 
reviewed all transcripts).
RESULTS
The ways in which the EMOS was implemented and 
adopted were conceptualised in four broad thematic 
categories: adoption of the system for information gath-
ering, perceptions of the system as new, perceptions of 
the EMOS as requiring technical competence and the 
interactions and relationships that involved individual or 
collective use of the technology.
Adoption of the system for information gathering
The EMOS facilitated the efficient acquisition of infor-
mation relating to the appropriateness of prescribing 
for individual patients. External structures provided the 
conditions for the use of the technology, specifically 
through the requirements of national policies relating to 
safe medicines use as set down by national governance and 
guidelines and the CCG’s responses to those requirements. 
The CCG was motivated to carry out audits of prescribing, 
and much of the data extracted through such audits were 
used to benchmark the CCG against these national poli-
cies and targets. This auditing was in turn determined 
by the policy and institutional climate that required the 
reporting of such auditing, the setting of certain guide-
lines and targets and the adherence to those. This further 
led to the CCG utilising the technology in a local context 
to monitor prescribing behaviour in practices in response 
to local initiatives. External structures such as national or 
local ‘initiatives’ worked with the internal structures (in 
this specific instance, the motivations of the CCG to report 
in response to these ‘initiatives’) and the material prop-
erties of the technology, to more swiftly identify patients 
registered with general practices that met the relevant 
prescribing safety audit. The material properties of the 
system shaped the ability to conduct extensive searches 
of electronic health records across multiple general prac-
tices in a relatively short space of time. According to the 
following extract from an interview with a CCG pharma-
cist, the technological structures enabled the collection of 
data in a more efficient and timely fashion.
[…]it’s a way of being able to gather pseudo-
anonymised individual patient data and relate it 
to ideas and thoughts around initiatives that CCG 
or the medicines management team are looking 
at that perhaps has been identified or highlighted 
nationally, or locally and it can all be done relatively 
quickly within a few seconds if necessary. So you don’t 
have to trawl round 17 different practices. (CCGP2)
Centrally, in a form of pay for performance initiative, the 
CCG made the EMOS part of a ‘GP incentive scheme 
to engage with alerts in a meaningful way’ (GP1-INT), 
and this was conceptualised as ‘trying to sort of get some 
more traction’ (GP1-INT). Guidelines and documents 
concerning strategies for prescribing framed the possibil-
ities for use ‘to actually monitor the progress against a sort 
of target outcome’ (GP1-INT). The functionality within 
the EMOS allowed for benchmarking across the CCG. 
This in turn provided for structures that could be utilised 
by the CCG to encourage practices to use the system and 
an infrastructure that supported their own activities in 
monitoring prescribing behaviour and to ‘reward good 
prescribing’ (GP1-INT).
‘if there are some practices that are demonstrating 
very good prescribing, then we’ve picked those out as 
well and highlighted those to act as a kind of beacon 
of hope for everybody else’. (CCGP2)
The system also allowed for communication channels and 
feedback, where contact with practices was through the 
system or as a result of alerts being sent out by email. Such 
communication, between the clinicians placed centrally 
at the CCG and the individual GP practices, enabled the 
CCG to monitor prescribing as ‘a way of looking at the 
map’ (GP2) as well as the use of the system by ‘tracking 
our advice in those practices’ (GP1-INT). The codes and 
material properties of the system facilitated monitoring 
in that logging on to the system indicated engagement 
with it. This in turn allowed the CCG to further monitor 
and audit prescribing patterns because they could swiftly 
see which practices had responded to alerts and ‘[could] 
have some kind of objective measure that [gave them] 
some idea as to who’s perhaps even more engaged than 
others’ (CCGP2). The ambitions and motivations of the 
CCG to monitor prescribing acted as an internal struc-
ture to work ‘very hard to get the uptake of that better’ 
(CCGP2) and in ‘trying to persuade our clinicians to 
use it so that we get a much more real time feedback’ 
(CCGP2). Furthermore, this combination of technolog-
ical infrastructure and the ambitions of the CCG created 
a new internal structure in the form of a convention for 
using the system.
(When) the GP logs onto the Eclipse system and 
there’s a little tick box to say patient reviewed […]. 
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Now some practices are doing that as a regular 
routine exercise, so that means that tracking our 
advice in those practices is very easy and what it does 
allow you to do as well is not to send the same alert 
out to the same practice again. (GP1-INT)
In this way, there were patterns of agent–technology 
relationships that reinforced a hierarchical agent–agent 
relationship within the network. The CCG managers were 
interacting with the technology to monitor prescribing 
since engagement at local clinician level with the system 
was encouraged by the CCG. Because it provided further 
feedback to them, agent–technology relationships could 
build through the system use as new agent–agent relation-
ships between managers centrally at the CCG and local 
GPs.
Perceptions of the system as new
Using the EMOS was characterised as a new practice 
that would require new approaches. Resistance towards 
the system was thus justified by characterising existing 
behaviours as ingrained. Here, habits and ways of doing 
things that were presented by one GP as ‘the old fash-
ioned way’ (CCGP2) provided for a limited use of the 
system. One such disposition was around their prescribing 
habits, which they described as ‘conservative’ (CCGP2). 
This allowed for a limited use of the EMOS, in which 
most alerts would not require action because prescribing 
behaviour was already ‘protective of patients’ (CCGP2). 
Similarly, as the following extract illustrates, non-use of 
the system resulted from habitual accustomed practice of 
using other systems, pre-existing routines and repetitive 
ways of doing things.
I think the trouble is Eclipse is another thing you 
have to log into along with the other 20 things you 
log into every day, and you're so used to using your 
other clinical system all the time. (GPM3)
In a further example of agent–agent relationships asso-
ciated with the use of the system, the CCG pharmacists 
were concerned that GPs would otherwise avoid using the 
system. It was assumed that GPs, in addition to training 
on the system, needed persuasion in order to ‘just [get] 
them to use it as habit’ (CCGP1).
but we have had a situation where the GP said, oh, 
I’m not sure if I’ll have time to look on Eclipse, but 
you can’t spoon feed them everything. (CCGP1)
Social structures could shape the ways things were done. 
Workplace routines and practices, such as the prioritisa-
tion of work schedules, acted as constraints or enablers 
to the use of the new system. Here this GP highlighted 
contingencies within the structures associated with the 
‘special circumstances of my workplace’ (GP4), which 
allowed for a range of actions from sidelining the alert 
through to reviewing the patient. In this way, the duality 
of structure—the specific demands of his work—and his 
agency—his interaction with the alerts in the EMOS—both 
governed his act of utilising the system and the extent and 
character of that utilisation.
[…] it can depend on the nature of the alerts, how 
urgent it seems, and the special circumstances of my 
workplace […] some things might actually get side-
lined for a few weeks if they’re not clinically urgent, 
but […] the next time I catch up with my paperwork 
then I’ll dig up that alert […] and review the situation. 
(GP4)
For the CCG pharmacist undertaking medication reviews 
in care homes, the system changed the way they worked 
because ‘if necessary if there’s something that comes up 
on Eclipse whilst we’re there we can, rather than having to 
go back to the surgery first, check it and then make a deci-
sion’ (CCGP1). In this way, the technology shaped their 
actions. Furthermore, the technological structures in the 
EMOS and the internal structures led to new shared deci-
sion making, use and outcome.
We can look on Eclipse and most of the time it’s on 
Eclipse and we can answer the question there and 
then. For example, we had a patient who was on 
Memantine, who was a really not very well gentleman, 
[…] so we phoned the GP straightaway. (CCGP1)
Perceptions of the EMOS as requiring technical competence
The EMOS was conceptualised as a ‘clever’ system that 
could conduct complex searches but would require tech-
nical knowledge on the part of users in order to do so. 
This allowed for this GP’s limited use of the system when 
combined with an understanding of his own abilities to 
use the system.
That’s how I become accustomed to doing things, 
which is perhaps why I then don’t use Eclipse, 
because I do think I might not have the ability and 
the power of making the use of a more powerful tool. 
But, perhaps I have also then learned useful habits 
with the old fashioned way. (GP4)
Non-use of the system was associated with the cognitive 
and physical demands associated with using the EMOS 
and finding time to learn how to get the best out of it. This 
further conceptualised the system as complex requiring 
time, training and ‘proper teaching’ (GPM2) to gain the 
expertise required to use it.
And if you had the time to log into it and go oh, what 
does this do? What does that do? […] You train your 
audit clerk who runs all sorts of searches and does all 
sorts of audit work, you could have the time to show 
her and teach her, […] I’d love to have the time to 
tinker with, (the system).[…] You’d need time to 
play with it and time to … proper teaching, proper 
(training) showing us what it does. (GPM2)
The conceptualisation of the EMOS as requiring tech-
nical competence was related to structures embedded 
within the technology that allowed for or constrained its 
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use. This could either empower users and thus facilitate 
further use or undermine that agency.
‘And also I’m computer literate and I can work 
out, I can problem solve because I’m reasonably 
well educated, if you were talking about average 
population here, they would either give up, they 
would probably have given up when they couldn’t log 
in’. (Pt2)
This service user conceptualises the system as difficult and 
one that required her abilities as a ‘computer literate’ to 
use it. This required an interaction of her capabilities and 
the structures within the system to engage with it, and 
difficulties with logging in was perceived to be a potential 
constraint for other users.
Interactions and relationships: individual, shared and 
collective use of the technology
There were variations in the ways the technology was used 
within collaborative networks of social relations. Different 
general practice staff took responsibility for using the 
technology; use depended on shared or collective roles, 
or on a hierarchical allocation of access.
For service users, using the technology was determined 
by networks of social relations. This was expressed as 
having support from medical professionals to understand 
the system.
But I think the important thing is before you sort 
of almost start using it, you do need that kind of 
intervention from a medical practitioner in some way 
to actually help you with the things you need to know. 
(Pt1)
Within general practices, there was variation in who 
took responsibility for the EMOS. On receiving an alert 
through the system, one practice manager would then 
‘pass it on to the GP and get them to respond to me’ (GPM 
2) and that ‘the doctors don’t access it at all. […] I’m the 
only one that, yeah, has anything to do with it’ (GPM 2). 
Another remarked,
I get the alert the same way through the email, I identify 
the patient […] then mine goes to the GP. But the GP 
actions it, I don’t have any more responsibility for it 
after that […] They go into Eclipse, they do it, […] 
my job is just to literally give them the information 
and they do the rest. (GPM1)
Such variation was driven by the conventions and norms 
associated with work practices. In different general prac-
tices, individuals were assigned to different roles and 
responsibilities often based on what worked best for the 
practice.
one of the GPs has been nominated within our 
practice to take that lead in the same way that we 
break our workload down in other areas; you be the 
lead for this and tell us if there’s anything we all need 
to know and share the workload. (GPM4)
The allocation of access to the EMOS limited its use. 
Community pharmacists did not have access to the system. 
Perceived social norms were seen as ‘historically a barrier’ 
(CP2) that perpetuated that lack of access. Community 
pharmacists attributed this barrier to GPs seeing them-
selves as ‘as the custodians of the patient record’ (CP2).
I think there always has been a conflict because 
GPs often see themselves as the custodians of the 
patient record and even though the information in 
that patient record, even abbreviated information is 
incredibly useful for community pharmacists, they’ve 
never successfully managed to allow us access and 
this is going back to EPS [Electronic Prescription 
Service], this is what EPS promised and it’s never 
happened. (CP2)
There was a perception that the system was a tool for the 
CCG. This differential access meant that the system had 
not been used in some general practices. There were 
however perceptions that the system had ‘evolved’.
I think that’s what it was […] originally purchased 
… or the agreement with Eclipse was originally for 
the meds management team to use it as a tool for 
them […] And I think Eclipse has evolved since that 
happened […] And I don't think any of us have kept 
up with how Eclipse has evolved and what else it can 
now do. (GPM3)
Such changes were related to social norms around owner-
ship and conventions concerning how the system would 
be used, centrally by the CCG to look at prescribing 
patterns across practices and by individual practices 
of their own prescribing audits. As the system evolved, 
there were perceptions that it could do more. In this way, 
perceptions of the technological structures and material 
properties of the technology drove the ambitions of some 
users to learn more about the potential uses of the system, 
which opened up access to different users.
DISCUSSION
The adoption and implementation of the EMOS was 
dependent on a dynamic mix of external structures, 
internal structures and material properties embedded 
in the technology. External infrastructures, motivations 
of users and material properties of the EMOS facilitated 
information gathering. Perceiving the system as new 
could lead to resistance and maintenance of habitual 
behaviours. Use was dependent on interactions and rela-
tionships between users. Use could be further constrained 
by conceptualising the system as requiring technical 
competence.
SST proposes that in order to act, agents draw on 
internal structures. These internal structures include 
dispositions and knowledge of the ‘strategic terrain’ 
of external structures.29 It has been suggested that to 
understand the implementation and adoption of IT 
from an SST standpoint, it is important to understand 
group.bmj.com on May 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
8 Jeffries M, et al. BMJ Open 2017;7:e014810. doi:10.1136/bmjopen-2016-014810
Open Access 
the context in which the IT is being introduced, the 
networks of people and technologies, the dispositions 
of actors in those networks, the material properties of 
the technology and how these shape human action.29 32 
In the present study, the contextual background was 
shaped by policy relating to medication safety and the 
requirement to benchmark against national prescribing 
and safety targets. CCG managers’ knowledge of the 
external structures relating to that policy background 
and their own skills and ambitions led to actions around 
the monitoring of prescribing behaviours across the 
CCG area. This was facilitated by material properties 
in the system. The outcomes of the monitoring actions 
were not just that prescribing data were gathered and 
reported to other institutions but that the external 
structures, the dispositions of the CCG managers and 
the material properties of the system allowed for gover-
nance and monitoring of clinician behaviours through 
tracking engagement with the system and processes of 
persuasion and reward. This could therefore have been 
said to reinforce hierarchical relationships between the 
CCG and the local GPs. Hence, the use of the system 
created new internal structures concerning such social 
rules and conventions. Similarly, in previous literature, 
information systems have been associated with enabling 
managers to capture information, place local clinicians 
under surveillance and make their actions calculable.39 
Furthermore, an effect of such surveillance is for indi-
viduals to adapt their own behaviour to ensure they act 
legitimately.40
Previous literature has established the role of social, 
organisational and work practices in the adoption of 
IT16 17; others have focused on functionality of design and 
tailoring to users18 41 or on top-down implementation.41 42 
Other research has indicated that emphasis on training 
might also construct end users as the problem.43 With 
notable exceptions,29 33 34 much of this earlier literature 
has highlighted the importance of work practices and 
how technology needs to be embedded into pre-existing 
routines but has not seen these dynamically linked to 
wider contexts particularly in the context of medication 
safety in primary care. In this study, we found that key 
agents in the network either resisted or sustained use of 
the system. GPs saw the system as new and unnecessary 
and not compatible with existing workplace routines. 
There were also differences in agents’ responses to the 
material properties in the system where these were seen as 
facilitating use by some agents and by others as a barrier 
to use because the material properties of the system were 
perceived as to make it to difficult to use. SST enabled 
us to understand these dispositional behaviours in rela-
tion to social structures, particularly pre-existing routines, 
work practices and social norms. In previous research, 
there has been a focus on interoperability, work practices 
and system usability, suggesting that poor adoption of IT 
is related to users or the system.19 41 This misses how inter-
actions and relationships between contexts, users and 
technology might work and how the implementation of 
IT is a social practice.39 In this study, these networks of 
social relations affected the use of the system.
Implications of the findings
SST would argue that individual agency is dependent on 
knowledge of rules and conventions. Primary care settings 
are governed by institutional norms, measures, rules and 
traditions, habits and behaviours.29 44 Some of these are 
embedded in local rules and conventions associated with 
the different working dynamics of individual practices, 
whereas others are found in regulations and gover-
nance associated with wider economic and institutional 
contexts.29 45 Using SST in this way may be particularly 
valuable in primary care research because general prac-
tices operate with their own organisational culture and 
dynamic, which may well lead to marked differences in 
working practices and structure.46
This study highlights how healthcare IT interventions 
are implemented and adopted in a complex social and 
organisational context. Interventions that are top-down 
and perceived as tools of managerial control are less likely 
to be effective than those that take into consideration 
existing local practices and the ambitions and attitudes of 
those who will use the technology.
STRENGTHS AND LIMITATIONS
Much of the previous literature on interventions to 
improve medication safety has focused on secondary 
healthcare settings, and electronic audit and feedback 
systems of the kind examined in this study are under-re-
searched in primary care. A particular strength of this 
study is the use of SST, which was found to be a useful 
theoretical approach to studying the implementation 
and adoption of the EMOS in a primary care setting. 
In applying this theoretical approach, we were able to 
see the differences in motivations, ambitions, aims and 
attitudes of different actors from different stakeholder 
groups towards the IT intervention. SST could also reveal 
the complex contextual background in which the EMOS 
was implemented, and it revealed how the implementa-
tion was informed by wider contexts. Hence, we were able 
to understand that the successful adoption of the EMOS 
was not merely dependent on agents but on the complex 
terrain in which it was implemented. Previous studies 
using this approach have focused on large national IT 
projects where institutional contexts might be consid-
ered to have more effect.32 47 We found, however, that in 
a smaller-scale project, wider policy institutional contexts 
did affect the implementation and adoption of the IT, 
for example, through the CCG’s response to the require-
ments of national policies. In this way, the use of the 
system depended on other factors alongside the disposi-
tions of the users.
There are several limitations to this work, which present 
further opportunities for future research examining the 
adoption and implementation of electronic audit and 
feedback systems to improve medication safety in primary 
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care settings. It has been suggested that studies such as 
these explore wider social contexts through analysis of 
background data and through ethnographic observa-
tion.35 48 Although we conducted one observation with 
a CCG pharmacist, this was only as an extension of the 
interview with that participant to elicit some further 
understanding of how they used the EMOS. A number 
of naturalistic observations would have been useful in 
unpicking contexts and agents’ choices and actions in 
using the system.
CONCLUSION
Our study examines the implementation and adoption of 
an IT system for medicine optimisation in primary care. 
It was found that the dynamic combination of external, 
internal and technological structures affected the adop-
tion and implementation of the system. IT interventions 
for medicine optimisation should consider how utilisa-
tion may depend on a combination of the infrastructure 
‘within’ primary care, the social structures embedded in 
the technology and the conventions, norms and disposi-
tions of those utilising it.
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